Increased matrix metalloproteinase-9 secretion in short-term tissue cultures of prostatic tumor cells

International Journal of Cancer

Volumn 69, Issue 5, 1996, Pages 386-393

  Festuccia, Claudio ^a   Bologna, Mauro ^a,b   Vicentini, Carlo ^b   Tacconelli, Antonella ^a   Miano, Roberto ^c   Violini, Stefania ^a   Mackay, Andrew R ^a  

^a UNIVERSITY OF L'AQUILA   (Italy)

^b UNIVERSITY OF L'AQUILA   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE; GELATINASE B; METALLOPROTEINASE;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; TISSUE CULTURE;

DIAGNOSIS, DIFFERENTIAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EPIDERMAL GROWTH FACTOR; EPITHELIUM; HUMANS; MALE; METALLOENDOPEPTIDASES; NEOPLASM STAGING; PROSTATIC NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0029829166     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19961021)69:5<386::AID-IJC6>3.0.CO;2-1     Document Type: Article

References (23)

1. BALLIN, M., GOMEZ, D.E., SIHNA, C.C. and Thorgeirsson, U.P.: ras oncogene mediated induction of a 92 KDa metalloproteinase; strong correlation with the malignant phenotype: induction by transfectin with c-Ha-ras but not c-Ha-ras plus Ad2-E1A. Biochem. Biophys. Res. Commun. 154:832-838 (1988)
2. BERNHARD, E.J., MUSCHEL, R.J. and HUGHES, E.N., Mr 92,000 gelatinase release correlates with the metastatic phenotype in transformed rat embryo cells. Cancer Res., 50, 3872-3877 (1990).
3. BOAG, A.H. and YOUNG, I.D., Immunohistochemical analysis of type IV collagenase expression in prostatic hyperplasia and adenocarcinoma. Mod. Pathol., 6, 65-68 (1993).
4. BOLOGNA, M., VICENTINI, C., FESTUCCIA, C., MUZI, P., NAPOLITANO, T., BIORDI, L. and MIANO, L., Short-term tissue culture of prostatic carcinoma samples provides useful biological parameters related to patient prognosis. Eur. Urol., 15, 243-247 (1988).
5. COHEN, D.W., SIMAK, R., FAIR, W.R., MELAMED, J., SCHER, H.I. and CORDON-CARDO, C., Expression of transforming growth factor alpha and the epidermal growth factor receptor in human prostate tissues. J. Urol., 152, 2120-2124 (1994).
6. COTTAM, D.W. and REES, R.C., Regulation of Matrixmetalloproteinases: their role in tumor invasion and metastasis. Int. J. Oncol., 2, 861-872 (1993).
7. FESTUCCIA, C., VICENTINI, C., FIRMA, N., DI PASQUALE, A.B., ACETO, G., ZAZZERONI, F., MIANO, L. and BOLOGNA, M., Plasminogen activator activities in short-term tissue cultures of benign prostatic hyperplasia and prostatic carcinoma. Oncol. Res., 7, 131-138 (1995).
8. HAMDY, F.C., COTTAM, D.W., REES, R.C. and WILLIAMS, J.L., Matrix metalloproteinase 9 expression in primary human prostatic adenocarcinoma and benign prostatic hyperplasia. Brit. J. Cancer, 69, 177-182 (1994).
9. IBRAHIM, G.K., KERNS, B., MACDONALD, J.A., IBRAHIM, S.N. and KINNEY, R.B., Differential immunoreactivity of epidermal growth factor receptor in benign, dysplastic and malignant prostatic tissues. J. Urol., 149, 170-178 (1993).
10. JEZIORSKA, M., HABOUBI, N.Y., SCHOFIELD, P.P., OGATA, Y., NAGASE, H. and WOOLLEY, D.E., Distribution of gelatinase B (MMP-9) and type IV collagen in colorectal carcinoma. Int. J. Colorectal Dis., 9, 141-148 (1994).
11. KLEINER, D.E. and STETLER-STEVENSON, W.G., Quantitative zymography: detection of picogram quantities of gelatinases. Anal. Biochem., 218, 325-329 (1994).
12. LOKJISHWAR, B.L., SELZER, M.G., BLOCK, N.L. and GUNJA-SMITH, Z., Secretion of matrix metalloproteinases and their inhibitors (tissue inhibitors of metalloproteinases) by human prostate in explant culture: reduced tissue inhibitor of metalloproteinase secretion by malignant tissue. Cancer Res., 53, 4493-4498 (1993).
13. MACKAY, A.R., BALLIN, M., PELINA, M.D., FARINA, A.R., NASON, A.M., HARTZLER, J.L. and THORGEIRSSON, U.P., Effect of phorbol ester and cytokines on matrix metalloproteinases and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines. Invasion Metastasis, 12, 168-184 (1992).
14. MACKAY, A.R., HARTLZER, J.L., PELINA, M. and THORGEIRSSON, U.P., Studies on the ability of 65 kDa and 92 kDa tumor cell gelatinases to degrade type IV collagen. J. biol. Chem., 265, 21929-21934 (1990).
15. MANN, E.A., HIBBS, M.S., SPIRO, J.D., BOWIK, C., WANG, X.Z., CLAWSON, M. and CHEN, L.L., Cytokines regulation of gelatinase production by head and neck squamous cell carcinoma: the role of tumor necrosis factor-alpha. Ann. Otol. Rhinol. Laryngol., 104, 203-209 (1995).
16. MOLL, U.M., YOUNGLEIB, G.L., ROSINSKI, K.B. and QUIGLEY, J.P., Tumor promoter-stimulated Mr92,000 type IV collagenase secreted by normal and malignant human cells; isolation and characterization of the enzyme from HT-1080 tumor cells. Cancer Res., 50, 6162-6170 (1990).
17. PAJOU, M.S., NAGLE, R.B., BREATHNACH, R., FINCH, J.S., BRAWER, M.K. and BOWDEN, G.T., Expression of metalloproteinase genes in human prostate cancer. J. Cancer Res. clin. Oncol., 117, 144-150 (1991).
18. RAK, J.W. and KERBEL, R.S., Growth advantage ("clonal dominance") of metastatically competent tumor cell variants expressed under selective two- or three-dimensional tissue culture conditions. In Vitro cell. dev. Biol. Anim., 29, 742-748 (1993).
19. SHIMA, T., SASAGURI, Y., KUSUKAWA, J., NAKANO, R., YAMANA, H., FUJITA, H., KAKEGAWA, T. and MORIMATSU, M., Production of matrix metalloproteinase 9 (92 kd gelatinase) by human oesophageal squamous cell carcinoma in response to epidermal growth factor. Brit. J. Cancer, 67, 721-727 (1993).
20. STEARNS, M.E., WANG, M. and STEARNS, M., Proteases and invasion by metastatic tumor cells-clinical implications for prostatic carcinoma. Int. J. Oncol., 4, 1013-1023 (1994).
21. VAN ANDEL, G., VLEEMINO, R., KURTH, K. and REIJKE, T.M., Incidental carcinoma of the prostate. Semin. Surg. Oncol., 11, 36-45 (1995).
22. WARE, J.L., Prostate cancer progression. Amer. J. Pathol., 145, 983-993 (1994).
23. ZUCKER, S., MANCUSO, P., DIMASSIMO, B., LYSIK, R.M. and CONNER, W.C., Comparison of techniques for measurement of gelatinase/type IV collagenases: enzyme-linked immunoassays versus substrate degradation assays. Clin. exp. Metastasis, 12, 13-23 (1994).